ONTOLOGY REPORT - ANNOTATIONS
| Term: | zoledronic acid |
|
| Accession: | CHEBI:46557
|
browse the term
|
| Definition: | An imidazole compound having a 2,2-bis(phosphono)-2-hydroxyethane-1-yl substituent at the 1-position. |
| Synonyms: | exact_synonym: | [1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid) |
| | related_synonym: | (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid; (1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid; C5H10N2O7P2; InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14); InChIKey=XRASPMIURGNCCH-UHFFFAOYSA-N; OC(Cn1ccnc1)(P(O)(O)=O)P(O)(O)=O; Reclast; ZOL |
| | xref_casrn: | 118072-93-8 |
| | xref: | Beilstein:9205049 "Beilstein Registry Number"; ChEMBL:183838 "ChEMBL COMPOUND"; ChemIDplus:118072-93-8 "CAS Registry Number"; DrugBank:118072-93-8 "CAS Registry Number"; DrugBank:DB00399 "DrugBank"; Gmelin:2609374 "Gmelin Registry Number"; KEGG DRUG:118072-93-8 "CAS Registry Number"; KEGG DRUG:D08689 "KEGG DRUG" |
| | xref_mesh: | MESH:C088658 |
| | xref: | PDBeChem:ZOL "PDBeChem"; Patent:US4939130 "Patent"; Wikipedia:Zoledronic_Acid "Wikipedia" |
|
|
zoledronic acid
|
| G |
Abca4 |
ATP-binding cassette, subfamily A (ABC1), member 4 |
|
increases expression |
ISO |
2 |
218,712,663 |
218,849,896 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases expression |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Acbd4 |
acyl-CoA binding domain containing 4 |
|
decreases expression |
ISO |
10 |
92,276,972 |
92,285,988 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
increases expression |
ISO |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
decreases activity |
ISO |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adam17 |
ADAM metallopeptidase domain 17 |
|
multiple interactions |
ISO |
6 |
41,882,432 |
41,930,755 |
RGD:6480464 |
CTD |
| G |
Adsl |
adenylosuccinate lyase |
|
decreases expression |
ISO |
7 |
119,223,582 |
119,248,151 |
RGD:6480464 |
CTD |
| G |
Akirin2 |
akirin 2 |
|
decreases expression |
ISO |
5 |
51,152,935 |
51,167,720 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1s1 |
AKT1 substrate 1 (proline-rich) |
|
increases expression |
ISO |
1 |
95,325,272 |
95,328,510 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
increases expression |
ISO |
12 |
6,245,808 |
6,269,796 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
multiple interactions |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
decreases activity |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Ankef1 |
ankyrin repeat and EF-hand domain containing 1 |
|
increases expression |
ISO |
3 |
124,609,149 |
124,645,194 |
RGD:6480464 |
CTD |
| G |
Ankrd10 |
ankyrin repeat domain 10 |
|
increases expression |
ISO |
16 |
82,719,075 |
82,742,218 |
RGD:6480464 |
CTD |
| G |
Apba3 |
amyloid beta (A4) precursor protein-binding, family A, member 3 |
|
decreases expression |
ISO |
7 |
9,930,024 |
9,934,446 |
RGD:6480464 |
CTD |
| G |
Aph1a |
anterior pharynx defective 1 homolog A (C. elegans) |
|
increases expression |
ISO |
2 |
190,679,692 |
190,683,202 |
RGD:6480464 |
CTD |
| G |
Api5 |
apoptosis inhibitor 5 |
|
increases expression |
ISO |
3 |
78,819,632 |
78,844,710 |
RGD:6480464 |
CTD |
| G |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
|
decreases expression |
ISO |
1 |
158,872,249 |
158,912,164 |
RGD:6480464 |
CTD |
| G |
Arhgap18 |
Rho GTPase activating protein 18 |
|
decreases expression |
ISO |
1 |
18,967,836 |
19,116,268 |
RGD:6480464 |
CTD |
| G |
Arhgap29 |
Rho GTPase activating protein 29 |
|
multiple interactions |
ISO |
2 |
218,619,428 |
218,679,087 |
RGD:6480464 |
CTD |
| G |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
|
multiple interactions |
ISO |
8 |
45,984,042 |
46,106,412 |
RGD:6480464 |
CTD |
| G |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
|
multiple interactions |
ISO |
16 |
2,595,636 |
2,665,051 |
RGD:6480464 |
CTD |
| G |
Arid2 |
AT rich interactive domain 2 (Arid-rfx like) |
|
decreases expression |
ISO |
7 |
134,959,992 |
135,077,477 |
RGD:6480464 |
CTD |
| G |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
|
increases expression |
ISO |
1 |
171,062,181 |
171,162,426 |
RGD:6480464 |
CTD |
| G |
Asic1 |
acid-sensing (proton-gated) ion channel 1 |
|
multiple interactions |
ISO |
7 |
138,414,656 |
138,443,272 |
RGD:6480464 |
CTD |
| G |
Asic1 |
acid-sensing (proton-gated) ion channel 1 |
|
decreases expression |
EXP |
7 |
138,414,656 |
138,443,272 |
RGD:6480464 |
CTD |
| G |
Atrx |
alpha thalassemia/mental retardation syndrome X-linked |
|
decreases expression |
ISO |
X |
93,903,794 |
94,051,337 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bag1 |
BCL2-associated athanogene |
|
increases expression |
ISO |
5 |
58,329,720 |
58,342,293 |
RGD:6480464 |
CTD |
| G |
Bag3 |
Bcl2-associated athanogene 3 |
|
increases expression |
ISO |
1 |
187,781,147 |
187,804,835 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
decreases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bbx |
bobby sox homolog (Drosophila) |
|
decreases expression |
ISO |
11 |
51,655,446 |
51,799,132 |
RGD:6480464 |
CTD |
| G |
Bcap29 |
B-cell receptor-associated protein 29 |
|
multiple interactions |
ISO |
6 |
49,464,362 |
49,504,424 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases response to substance |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2a1 |
BCL2-related protein A1 |
|
decreases expression |
ISO |
8 |
94,045,109 |
94,053,777 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l10 |
BCL2-like 10 (apoptosis facilitator) |
|
affects expression |
ISO |
8 |
80,172,804 |
80,178,851 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
multiple interactions |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcl2l2 |
Bcl2-like 2 |
|
increases expression |
ISO |
15 |
32,983,165 |
32,988,018 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma-carboxyglutamate (gla) protein |
|
increases expression |
ISO |
2 |
180,482,313 |
180,483,290 |
RGD:6480464 |
CTD |
| G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
|
multiple interactions |
ISO |
4 |
144,139,486 |
144,145,186 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
increases expression |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
multiple interactions |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
decreases expression |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc6 |
baculoviral IAP repeat-containing 6 |
|
decreases expression |
ISO |
6 |
20,655,186 |
20,848,961 |
RGD:6480464 |
CTD |
| G |
Bloc1s5 |
biogenesis of lysosomal organelles complex-1, subunit 5, muted |
|
increases expression |
ISO |
17 |
32,240,737 |
32,266,040 |
RGD:6480464 |
CTD |
| G |
Bmp1 |
bone morphogenetic protein 1 |
|
increases expression |
ISO |
15 |
50,878,144 |
50,922,313 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
increases expression |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
increases expression |
ISO |
9 |
58,327,587 |
58,436,057 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
decreases expression |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Brca2 |
breast cancer 2, early onset |
|
increases expression |
ISO |
12 |
4,282,952 |
4,323,693 |
RGD:6480464 |
CTD |
| G |
Brip1 |
BRCA1 interacting protein C-terminal helicase 1 |
|
increases expression |
ISO |
10 |
74,313,004 |
74,436,532 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
multiple interactions |
ISO |
3 |
115,323,510 |
115,354,906 |
RGD:6480464 |
CTD |
| G |
Calml4 |
calmodulin-like 4 |
|
decreases expression |
ISO |
8 |
67,007,122 |
67,018,886 |
RGD:6480464 |
CTD |
| G |
Cant1 |
calcium activated nucleotidase 1 |
|
increases expression |
ISO |
10 |
108,405,355 |
108,420,225 |
RGD:6480464 |
CTD |
| G |
Caprin1 |
cell cycle associated protein 1 |
|
increases expression |
ISO |
3 |
89,062,097 |
89,093,093 |
RGD:6480464 |
CTD |
| G |
Cars |
cysteinyl-tRNA synthetase |
|
increases expression |
ISO |
1 |
203,934,812 |
203,977,042 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
affects expression |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
multiple interactions |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp14 |
caspase 14 |
|
decreases expression |
ISO |
7 |
12,487,166 |
12,489,998 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
affects expression |
ISO |
4 |
70,029,728 |
70,047,164 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
increases activity |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cbx5 |
chromobox homolog 5 |
|
increases expression |
ISO |
7 |
142,107,922 |
142,125,543 |
RGD:6480464 |
CTD |
| G |
Ccdc138 |
coiled-coil domain containing 138 |
|
increases expression |
ISO |
20 |
37,181,926 |
37,269,631 |
RGD:6480464 |
CTD |
| G |
Ccdc64 |
coiled-coil domain containing 64 |
|
increases expression |
ISO |
12 |
42,139,165 |
42,227,651 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
increases expression |
ISO |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
increases expression |
ISO |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Cd27 |
CD27 molecule |
|
affects expression |
ISO |
4 |
161,351,797 |
161,356,688 |
RGD:6480464 |
CTD |
| G |
Cd40lg |
CD40 ligand |
|
decreases expression |
ISO |
X |
141,925,019 |
141,937,183 |
RGD:6480464 |
CTD |
| G |
Cd55 |
Cd55 molecule |
|
increases expression |
ISO |
13 |
43,322,246 |
43,348,334 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
increases expression |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
decreases expression |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
increases expression |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
multiple interactions |
ISO |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
multiple interactions |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
|
multiple interactions |
ISO |
1 |
206,681,430 |
206,683,098 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
increases expression |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdv3 |
carnitine deficiency-associated gene expressed in ventricle 3 homolog (mouse) |
|
increases expression |
ISO |
8 |
108,365,896 |
108,376,263 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
increases expression |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
decreases farnesylation |
ISO |
13 |
105,920,242 |
105,965,655 |
RGD:6480464 |
CTD |
| G |
Cenpi |
centromere protein I |
|
increases expression |
ISO |
X |
121,786,667 |
121,837,546 |
RGD:6480464 |
CTD |
| G |
Cep120 |
centrosomal protein 120 |
|
increases expression |
ISO |
18 |
49,192,432 |
49,255,022 |
RGD:6480464 |
CTD |
| G |
Cep57 |
centrosomal protein 57 |
|
increases expression |
ISO |
8 |
10,608,688 |
10,627,914 |
RGD:6480464 |
CTD |
| G |
Chac1 |
ChaC, cation transport regulator homolog 1 (E. coli) |
|
increases expression |
ISO |
3 |
105,869,762 |
105,873,332 |
RGD:6480464 |
CTD |
| G |
Chmp4b |
charged multivesicular body protein 4B |
|
increases expression |
ISO |
3 |
145,138,905 |
145,176,471 |
RGD:6480464 |
CTD |
| G |
Chmp4bl1 |
chromatin modifying protein 4B-like 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
|
multiple interactions |
ISO |
17 |
19,423,502 |
19,429,451 |
RGD:6480464 |
CTD |
| G |
Cldn3 |
claudin 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Coq4 |
coenzyme Q4 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
3 |
8,775,412 |
8,783,745 |
RGD:6480464 |
CTD |
| G |
Cox17 |
cytochrome c oxidase assembly homolog 17 (yeast) |
|
decreases expression |
ISO |
11 |
64,183,573 |
64,185,985 |
RGD:6480464 |
CTD |
| G |
Cpd |
carboxypeptidase D |
|
increases expression |
ISO |
10 |
67,327,272 |
67,390,836 |
RGD:6480464 |
CTD |
| G |
Cpne3 |
copine III |
|
increases expression |
ISO |
5 |
34,154,672 |
34,203,959 |
RGD:6480464 |
CTD |
| G |
Crls1 |
cardiolipin synthase 1 |
|
decreases expression |
ISO |
3 |
120,647,517 |
120,666,325 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
decreases expression |
ISO |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Ctbs |
chitobiase, di-N-acetyl- |
|
increases expression |
ISO |
2 |
244,648,365 |
244,662,878 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
decreases expression |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctu2 |
cytosolic thiouridylase subunit 2 homolog (S. pombe) |
|
decreases expression |
ISO |
19 |
52,765,786 |
52,771,016 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cyb5r3 |
cytochrome b5 reductase 3 |
|
increases expression |
ISO |
7 |
121,187,821 |
121,205,382 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
multiple interactions |
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
decreases expression |
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
decreases expression |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Dapp1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides |
|
increases expression |
ISO |
2 |
235,423,487 |
235,474,068 |
RGD:6480464 |
CTD |
| G |
Dcaf15 |
DDB1 and CUL4 associated factor 15 |
|
increases expression |
ISO |
19 |
25,737,953 |
25,745,353 |
RGD:6480464 |
CTD |
| G |
Dcun1d4 |
DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae) |
|
increases expression |
ISO |
14 |
37,051,133 |
37,128,945 |
RGD:6480464 |
CTD |
| G |
Ddx42 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 |
|
increases expression |
ISO |
10 |
95,612,667 |
95,644,162 |
RGD:6480464 |
CTD |
| G |
Dffa |
DNA fragmentation factor, alpha subunit |
|
decreases expression |
ISO |
5 |
166,179,130 |
166,192,029 |
RGD:6480464 |
CTD |
| G |
Dhx35 |
DEAH (Asp-Glu-Ala-His) box polypeptide 35 |
|
increases expression |
ISO |
3 |
149,532,510 |
149,589,678 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
multiple interactions |
ISO |
12 |
34,196,347 |
34,209,633 |
RGD:6480464 |
CTD |
| G |
Dlg1 |
discs, large homolog 1 (Drosophila) |
|
increases expression |
ISO |
11 |
70,735,283 |
70,930,374 |
RGD:6480464 |
CTD |
| G |
Dlgap4 |
discs, large (Drosophila) homolog-associated protein 4 |
|
decreases expression |
ISO |
3 |
147,081,222 |
147,176,024 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
increases expression |
ISO |
6 |
63,583,033 |
63,587,247 |
RGD:6480464 |
CTD |
| G |
Dnase1l1 |
deoxyribonuclease 1-like 1 |
|
increases expression |
ISO |
X |
160,327,966 |
160,336,447 |
RGD:6480464 |
CTD |
| G |
Dpp9 |
dipeptidyl peptidase 9 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dtwd2 |
DTW domain containing 2 |
|
decreases expression |
ISO |
18 |
44,628,808 |
44,718,486 |
RGD:6480464 |
CTD |
| G |
Dtx3 |
deltex homolog 3 (Drosophila) |
|
increases expression |
ISO |
7 |
67,145,276 |
67,149,937 |
RGD:6480464 |
CTD |
| G |
Dusp18 |
dual specificity phosphatase 18 |
|
increases expression |
ISO |
14 |
84,555,975 |
84,560,365 |
RGD:6480464 |
CTD |
| G |
Egln2 |
EGL nine homolog 2 (C. elegans) |
|
increases expression |
ISO |
1 |
82,233,239 |
82,240,990 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr2 |
early growth response 2 |
|
increases expression |
ISO |
20 |
21,883,885 |
21,888,177 |
RGD:6480464 |
CTD |
| G |
Egr4 |
early growth response 4 |
|
increases expression |
ISO |
4 |
119,765,289 |
119,767,612 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
increases expression |
ISO |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Ell2 |
elongation factor RNA polymerase II 2 |
|
increases expression |
ISO |
2 |
2,724,984 |
2,794,397 |
RGD:6480464 |
CTD |
| G |
Eml4 |
echinoderm microtubule associated protein like 4 |
|
increases expression |
ISO |
6 |
6,754,664 |
6,813,231 |
RGD:6480464 |
CTD |
| G |
Emp3 |
epithelial membrane protein 3 |
|
multiple interactions |
ISO |
1 |
96,389,783 |
96,392,960 |
RGD:6480464 |
CTD |
| G |
Emp3 |
epithelial membrane protein 3 |
|
increases expression |
ISO |
1 |
96,389,783 |
96,392,960 |
RGD:6480464 |
CTD |
| G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
multiple interactions |
ISO |
9 |
43,248,023 |
43,293,196 |
RGD:6480464 |
CTD |
| G |
Erg |
v-ets erythroblastosis virus E26 oncogene homolog (avian) |
|
multiple interactions |
ISO |
11 |
35,655,563 |
35,760,055 |
RGD:6480464 |
CTD |
| G |
Erlin1 |
ER lipid raft associated 1 |
|
increases expression |
ISO |
1 |
249,161,437 |
249,196,760 |
RGD:6480464 |
CTD |
| G |
Esco2 |
establishment of cohesion 1 homolog 2 (S. cerevisiae) |
|
increases expression |
ISO |
15 |
45,239,871 |
45,254,898 |
RGD:6480464 |
CTD |
| G |
Exoc5 |
exocyst complex component 5 |
|
increases expression |
ISO |
15 |
25,008,521 |
25,053,098 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
increases expression |
ISO |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
Fadd |
Fas (TNFRSF6)-associated via death domain |
|
multiple interactions |
ISO |
1 |
205,010,363 |
205,012,768 |
RGD:6480464 |
CTD |
| G |
Fads3 |
fatty acid desaturase 3 |
|
increases expression |
ISO |
1 |
212,489,224 |
212,506,444 |
RGD:6480464 |
CTD |
| G |
Fam222b |
family with sequence similarity 222, member B |
|
decreases expression |
ISO |
10 |
64,478,951 |
64,482,790 |
RGD:6480464 |
CTD |
| G |
Fam57a |
family with sequence similarity 57, member A |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
affects expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fbn1 |
fibrillin 1 |
|
increases expression |
ISO |
3 |
112,608,480 |
112,804,118 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
multiple interactions |
ISO |
15 |
42,425,336 |
42,453,390 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
increases expression |
EXP |
15 |
42,425,336 |
42,453,390 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
affects binding |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
increases activity |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
decreases activity |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
multiple interactions |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
decreases activity |
EXP |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
increases expression |
EXP |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
decreases activity |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
decreases activity |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
decreases activity |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
decreases activity |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
decreases activity |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
decreases activity |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fem1b |
fem-1 homolog b (C. elegans) |
|
increases expression |
ISO |
8 |
66,948,714 |
66,961,986 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
multiple interactions |
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
multiple interactions |
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
increases expression |
ISO |
X |
141,315,765 |
141,329,278 |
RGD:6480464 |
CTD |
| G |
Fignl1 |
fidgetin-like 1 |
|
increases expression |
ISO |
14 |
92,685,445 |
92,693,967 |
RGD:6480464 |
CTD |
| G |
Fnta |
farnesyltransferase, CAAX box, alpha |
|
multiple interactions |
ISO |
16 |
70,440,340 |
70,458,433 |
RGD:6480464 |
CTD |
| G |
Fopnl |
FGFR1OP N-terminal like |
|
increases expression |
ISO |
10 |
635,532 |
658,264 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fscn1 |
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
multiple interactions |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
increases expression |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Ggps1 |
geranylgeranyl diphosphate synthase 1 |
|
decreases activity |
ISO |
17 |
59,458,469 |
59,470,856 |
RGD:6480464 |
CTD |
| G |
Gk |
glycerol kinase |
|
increases expression |
ISO |
X |
72,416,872 |
72,493,296 |
RGD:6480464 |
CTD |
| G |
Glg1 |
golgi glycoprotein 1 |
|
decreases expression |
ISO |
19 |
41,082,324 |
41,176,959 |
RGD:6480464 |
CTD |
| G |
Glipr1 |
GLI pathogenesis-related 1 |
|
decreases expression |
ISO |
7 |
51,081,712 |
51,092,707 |
RGD:6480464 |
CTD |
| G |
Glrx3 |
glutaredoxin 3 |
|
decreases expression |
ISO |
1 |
197,176,020 |
197,206,249 |
RGD:6480464 |
CTD |
| G |
Gnb4 |
guanine nucleotide binding protein (G protein), beta polypeptide 4 |
|
increases expression |
ISO |
2 |
118,791,192 |
118,827,413 |
RGD:6480464 |
CTD |
| G |
Gtf2i |
general transcription factor II I |
|
increases expression |
ISO |
12 |
23,470,042 |
23,545,621 |
RGD:6480464 |
CTD |
| G |
Gtf3c4 |
general transcription factor IIIC, polypeptide 4 |
|
increases expression |
ISO |
3 |
7,834,130 |
7,849,247 |
RGD:6480464 |
CTD |
| G |
Gtpbp2 |
GTP binding protein 2 |
|
increases expression |
ISO |
9 |
10,377,808 |
10,385,845 |
RGD:6480464 |
CTD |
| G |
Gzmb |
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
|
affects expression |
ISO |
15 |
35,195,075 |
35,198,506 |
RGD:6480464 |
CTD |
| G |
Gzmb |
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
|
multiple interactions |
ISO |
15 |
35,195,075 |
35,198,506 |
RGD:6480464 |
CTD |
| G |
Gzmbl2 |
Granzyme B-like 2 |
|
multiple interactions |
ISO |
15 |
35,061,676 |
35,074,048 |
RGD:6480464 |
CTD |
| G |
Gzmbl2 |
Granzyme B-like 2 |
|
affects expression |
ISO |
15 |
35,061,676 |
35,074,048 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
increases expression |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
Herc4 |
HECT and RLD domain containing E3 ubiquitin protein ligase 4 |
|
decreases expression |
ISO |
20 |
25,591,774 |
25,665,597 |
RGD:6480464 |
CTD |
| G |
Hmox2 |
heme oxygenase (decycling) 2 |
|
multiple interactions |
ISO |
10 |
10,914,157 |
10,929,448 |
RGD:6480464 |
CTD |
| G |
Hp1bp3 |
heterochromatin protein 1, binding protein 3 |
|
increases expression |
ISO |
5 |
156,996,670 |
157,024,045 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
decreases localization |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hs3st3b1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 |
|
decreases expression |
ISO |
10 |
50,118,357 |
50,151,712 |
RGD:6480464 |
CTD |
| G |
Htr4 |
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
|
increases expression |
ISO |
18 |
58,417,163 |
58,468,888 |
RGD:6480464 |
CTD |
| G |
Ibsp |
integrin-binding sialoprotein |
|
multiple interactions |
ISO |
14 |
6,548,541 |
6,561,165 |
RGD:6480464 |
CTD |
| G |
Ibsp |
integrin-binding sialoprotein |
|
increases expression |
ISO |
14 |
6,548,541 |
6,561,165 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
multiple interactions |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
|
increases expression |
EXP |
17 |
72,557,196 |
72,563,149 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ift81 |
intraflagellar transport 81 homolog (Chlamydomonas) |
|
decreases expression |
ISO |
12 |
35,141,656 |
35,211,847 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
multiple interactions |
ISO |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Ikzf5 |
IKAROS family zinc finger 5 |
|
decreases expression |
ISO |
1 |
190,969,408 |
190,987,454 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il10ra |
interleukin 10 receptor, alpha |
|
multiple interactions |
ISO |
8 |
48,211,040 |
48,224,439 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il23a |
Interleukin 23, alpha subunit p19 |
|
increases expression |
ISO |
7 |
1,584,112 |
1,586,226 |
RGD:6480464 |
CTD |
| G |
Il2rg |
interleukin 2 receptor, gamma |
|
multiple interactions |
ISO |
X |
89,342,055 |
89,345,715 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
increases expression |
ISO |
7 |
67,308,713 |
67,310,138 |
RGD:6480464 |
CTD |
| G |
Ireb2 |
iron responsive element binding protein 2 |
|
increases expression |
ISO |
8 |
58,433,218 |
58,477,305 |
RGD:6480464 |
CTD |
| G |
Irf2bp1 |
interferon regulatory factor 2 binding protein 1 |
|
decreases expression |
ISO |
1 |
78,358,171 |
78,360,872 |
RGD:6480464 |
CTD |
| G |
Jak3 |
Janus kinase 3 |
|
increases expression |
ISO |
16 |
18,878,139 |
18,889,441 |
RGD:6480464 |
CTD |
| G |
Kbtbd2 |
kelch repeat and BTB (POZ) domain containing 2 |
|
increases expression |
ISO |
4 |
85,733,475 |
85,755,741 |
RGD:6480464 |
CTD |
| G |
Kctd5 |
potassium channel tetramerisation domain containing 5 |
|
increases expression |
ISO |
10 |
13,298,236 |
13,324,219 |
RGD:6480464 |
CTD |
| G |
Kif20a |
kinesin family member 20A |
|
decreases expression |
ISO |
18 |
27,100,044 |
27,108,530 |
RGD:6480464 |
CTD |
| G |
Klf11 |
Kruppel-like factor 11 |
|
increases expression |
ISO |
6 |
42,296,221 |
42,307,925 |
RGD:6480464 |
CTD |
| G |
Klf7 |
Kruppel-like factor 7 (ubiquitous) |
|
increases expression |
ISO |
9 |
62,690,536 |
62,738,089 |
RGD:6480464 |
CTD |
| G |
Klhl23 |
kelch-like family member 23 |
|
increases expression |
ISO |
3 |
51,964,759 |
51,978,330 |
RGD:6480464 |
CTD |
| G |
Krcc1 |
lysine-rich coiled-coil 1 |
|
increases expression |
ISO |
4 |
104,483,865 |
104,496,846 |
RGD:6480464 |
CTD |
| G |
Lama3 |
laminin, alpha 3 |
|
increases expression |
ISO |
18 |
4,030,463 |
4,121,355 |
RGD:6480464 |
CTD |
| G |
Lama5 |
laminin, alpha 5 |
|
multiple interactions |
ISO |
3 |
169,233,897 |
169,282,410 |
RGD:6480464 |
CTD |
| G |
Ldlr |
low density lipoprotein receptor |
|
increases expression |
ISO |
8 |
20,824,040 |
20,846,920 |
RGD:6480464 |
CTD |
| G |
Lhx3 |
LIM homeobox 3 |
|
increases expression |
ISO |
3 |
4,381,890 |
4,389,132 |
RGD:6480464 |
CTD |
| G |
Lin52 |
lin-52 homolog (C. elegans) |
|
increases expression |
ISO |
6 |
108,516,945 |
108,601,602 |
RGD:6480464 |
CTD |
| G |
Lins |
lines homolog (Drosophila) |
|
increases expression |
ISO |
1 |
121,162,852 |
121,169,099 |
RGD:6480464 |
CTD |
| G |
Lmna |
lamin A/C |
|
decreases farnesylation |
ISO |
2 |
180,595,724 |
180,616,354 |
RGD:6480464 |
CTD |
| G |
Lnpep |
leucyl/cystinyl aminopeptidase |
|
increases expression |
ISO |
1 |
56,063,361 |
56,151,257 |
RGD:6480464 |
CTD |
| G |
LOC100360940 |
diablo-like |
|
multiple interactions |
ISO |
5 |
148,562,065 |
148,563,619 |
RGD:6480464 |
CTD |
| G |
LOC679835 |
similar to Anionic trypsin II precursor (Pretrypsinogen II) |
|
increases expression |
ISO |
4 |
69,144,579 |
69,149,045 |
RGD:6480464 |
CTD |
| G |
Lphn1 |
latrophilin 1 |
|
decreases expression |
ISO |
19 |
25,891,157 |
25,931,128 |
RGD:6480464 |
CTD |
| G |
Lpin1 |
lipin 1 |
|
increases expression |
ISO |
6 |
40,253,664 |
40,297,195 |
RGD:6480464 |
CTD |
| G |
Lrrc14 |
leucine rich repeat containing 14 |
|
increases expression |
ISO |
7 |
114,760,919 |
114,766,477 |
RGD:6480464 |
CTD |
| G |
Lss |
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
|
increases expression |
EXP |
20 |
12,507,575 |
12,534,612 |
RGD:6480464 |
CTD |
| G |
Ltbr |
lymphotoxin beta receptor (TNFR superfamily, member 3) |
|
increases expression |
ISO |
4 |
161,431,864 |
161,438,265 |
RGD:6480464 |
CTD |
| G |
Ltbr |
lymphotoxin beta receptor (TNFR superfamily, member 3) |
|
multiple interactions |
ISO |
4 |
161,431,864 |
161,438,265 |
RGD:6480464 |
CTD |
| G |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
|
multiple interactions |
ISO |
16 |
22,243,137 |
22,300,978 |
RGD:6480464 |
CTD |
| G |
Map3k2 |
mitogen activated protein kinase kinase kinase 2 |
|
decreases expression |
ISO |
18 |
24,606,219 |
24,672,732 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Max |
MYC associated factor X |
|
increases expression |
ISO |
6 |
99,529,905 |
99,553,851 |
RGD:6480464 |
CTD |
| G |
Mbtps2 |
membrane-bound transcription factor peptidase, site 2 |
|
increases expression |
ISO |
X |
58,708,065 |
58,757,022 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mcm2 |
minichromosome maintenance complex component 2 |
|
multiple interactions |
ISO |
4 |
122,977,522 |
122,991,934 |
RGD:6480464 |
CTD |
| G |
Mcm2 |
minichromosome maintenance complex component 2 |
|
decreases expression |
ISO |
4 |
122,977,522 |
122,991,934 |
RGD:6480464 |
CTD |
| G |
Mcm4 |
minichromosome maintenance complex component 4 |
|
increases expression |
ISO |
11 |
87,169,742 |
87,183,443 |
RGD:6480464 |
CTD |
| G |
Mdk |
midkine |
|
multiple interactions |
ISO |
3 |
76,309,988 |
76,311,345 |
RGD:6480464 |
CTD |
| G |
Mdm4 |
Mdm4 p53 binding protein homolog (mouse) |
|
increases expression |
ISO |
13 |
45,895,832 |
45,931,421 |
RGD:6480464 |
CTD |
| G |
Med13l |
mediator complex subunit 13-like |
|
decreases expression |
ISO |
12 |
39,136,265 |
39,181,221 |
RGD:6480464 |
CTD |
| G |
Med20 |
mediator complex subunit 20 |
|
increases expression |
ISO |
9 |
8,836,460 |
8,839,869 |
RGD:6480464 |
CTD |
| G |
Med23 |
mediator complex subunit 23 |
|
multiple interactions |
ISO |
1 |
21,013,168 |
21,060,313 |
RGD:6480464 |
CTD |
| G |
Mex3c |
mex-3 homolog C (C. elegans) |
|
increases expression |
ISO |
18 |
70,355,267 |
70,376,424 |
RGD:6480464 |
CTD |
| G |
Mink1 |
misshapen-like kinase 1 |
|
decreases expression |
ISO |
10 |
57,443,253 |
57,496,763 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
multiple interactions |
ISO |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mmel1 |
membrane metallo-endopeptidase-like 1 |
|
increases expression |
ISO |
5 |
171,675,007 |
171,703,353 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mpdu1 |
mannose-P-dolichol utilization defect 1 |
|
increases expression |
ISO |
10 |
56,474,179 |
56,480,188 |
RGD:6480464 |
CTD |
| G |
Mphosph8 |
M-phase phosphoprotein 8 |
|
multiple interactions |
ISO |
15 |
35,667,102 |
35,694,910 |
RGD:6480464 |
CTD |
| G |
Mpp5 |
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) |
|
multiple interactions |
ISO |
6 |
101,414,657 |
101,471,504 |
RGD:6480464 |
CTD |
| G |
Mreg |
melanoregulin |
|
increases expression |
ISO |
9 |
71,303,627 |
71,357,985 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
affects localization |
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
decreases expression |
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:6480464 |
CTD |
| G |
Msh3 |
mutS homolog 3 (E. coli) |
|
increases expression |
ISO |
2 |
22,462,934 |
22,606,874 |
RGD:6480464 |
CTD |
| G |
Mterfd2 |
MTERF domain containing 2 |
|
increases expression |
ISO |
9 |
92,572,064 |
92,576,740 |
RGD:6480464 |
CTD |
| G |
Mtpap |
mitochondrial poly(A) polymerase |
|
increases expression |
ISO |
17 |
61,847,984 |
61,868,867 |
RGD:6480464 |
CTD |
| G |
Mvk |
mevalonate kinase |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mvp |
major vault protein |
|
increases expression |
ISO |
1 |
186,164,811 |
186,192,802 |
RGD:6480464 |
CTD |
| G |
Mvp |
major vault protein |
|
decreases expression |
ISO |
1 |
186,164,811 |
186,192,802 |
RGD:6480464 |
CTD |
| G |
N4bp2l1 |
NEDD4 binding protein 2-like 1 |
|
increases expression |
ISO |
12 |
4,256,571 |
4,280,941 |
RGD:6480464 |
CTD |
| G |
Nanos1 |
nanos homolog 1 (Drosophila) |
|
increases expression |
ISO |
1 |
267,364,669 |
267,365,460 |
RGD:6480464 |
CTD |
| G |
Nbr1 |
neighbor of Brca1 gene 1 |
|
increases expression |
ISO |
10 |
90,573,671 |
90,601,807 |
RGD:6480464 |
CTD |
| G |
Ndc80 |
NDC80 kinetochore complex component |
|
multiple interactions |
ISO |
9 |
110,702,935 |
110,718,894 |
RGD:6480464 |
CTD |
| G |
Nde1 |
nudE nuclear distribution E homolog 1 (A. nidulans) |
|
increases expression |
ISO |
10 |
777,877 |
814,260 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l3 |
nuclear factor, erythroid derived 2, like 3 |
|
decreases expression |
ISO |
4 |
79,668,259 |
79,695,648 |
RGD:6480464 |
CTD |
| G |
Nkrf |
NFKB repressing factor |
|
decreases expression |
ISO |
X |
7,962,136 |
7,978,566 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Npat |
nuclear protein, ataxia-telangiectasia locus |
|
increases expression |
ISO |
8 |
56,997,121 |
57,034,888 |
RGD:6480464 |
CTD |
| G |
Nrep |
neuronal regeneration related protein |
|
increases expression |
ISO |
18 |
25,842,127 |
25,868,219 |
RGD:6480464 |
CTD |
| G |
Nxt2 |
nuclear transport factor 2-like export factor 2 |
|
increases expression |
ISO |
X |
36,312,609 |
36,318,816 |
RGD:6480464 |
CTD |
| G |
Olr131 |
olfactory receptor 131 |
|
increases expression |
ISO |
1 |
161,697,243 |
161,698,166 |
RGD:6480464 |
CTD |
| G |
Optn |
optineurin |
|
multiple interactions |
ISO |
17 |
84,298,122 |
84,348,330 |
RGD:6480464 |
CTD |
| G |
Osgepl1 |
O-sialoglycoprotein endopeptidase-like 1 |
|
decreases expression |
ISO |
9 |
45,164,778 |
45,178,715 |
RGD:6480464 |
CTD |
| G |
P4hb |
prolyl 4-hydroxylase, beta polypeptide |
|
increases expression |
ISO |
10 |
109,950,221 |
109,961,716 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pcgf5 |
polycomb group ring finger 5 |
|
increases expression |
ISO |
1 |
240,564,487 |
240,689,320 |
RGD:6480464 |
CTD |
| G |
Pcyox1 |
prenylcysteine oxidase 1 |
|
increases expression |
ISO |
4 |
120,569,436 |
120,580,273 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
multiple interactions |
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdlim7 |
PDZ and LIM domain 7 |
|
increases expression |
ISO |
17 |
15,168,835 |
15,183,983 |
RGD:6480464 |
CTD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
multiple interactions |
ISO |
10 |
96,056,220 |
96,057,232 |
RGD:6480464 |
CTD |
| G |
Pglyrp4 |
peptidoglycan recognition protein 4 |
|
increases expression |
ISO |
2 |
183,015,945 |
183,038,181 |
RGD:6480464 |
CTD |
| G |
Phpt1 |
phosphohistidine phosphatase 1 |
|
increases expression |
ISO |
3 |
3,744,947 |
3,746,346 |
RGD:6480464 |
CTD |
| G |
Pik3c2a |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha |
|
increases expression |
ISO |
1 |
174,430,831 |
174,537,706 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases expression |
ISO |
15 |
3,680,072 |
3,686,232 |
RGD:6480464 |
CTD |
| G |
Plek |
pleckstrin |
|
increases expression |
ISO |
14 |
97,841,595 |
97,875,052 |
RGD:6480464 |
CTD |
| G |
Plk1 |
polo-like kinase 1 |
|
decreases expression |
ISO |
1 |
181,002,811 |
181,012,741 |
RGD:6480464 |
CTD |
| G |
Pnrc2 |
proline-rich nuclear receptor coactivator 2 |
|
increases expression |
ISO |
5 |
154,652,576 |
154,655,560 |
RGD:6480464 |
CTD |
| G |
Polr2a |
polymerase (RNA) II (DNA directed) polypeptide A |
|
decreases expression |
ISO |
10 |
56,552,872 |
56,579,172 |
RGD:6480464 |
CTD |
| G |
Polr2d |
polymerase (RNA) II (DNA directed) polypeptide D |
|
increases expression |
ISO |
18 |
24,205,326 |
24,212,458 |
RGD:6480464 |
CTD |
| G |
Pomgnt1 |
protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase |
|
increases expression |
ISO |
5 |
136,429,379 |
136,439,254 |
RGD:6480464 |
CTD |
| G |
Pon2 |
paraoxonase 2 |
|
multiple interactions |
ISO |
4 |
30,033,229 |
30,068,643 |
RGD:6480464 |
CTD |
| G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
multiple interactions |
ISO |
1 |
95,994,023 |
95,997,080 |
RGD:6480464 |
CTD |
| G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
increases expression |
ISO |
1 |
95,994,023 |
95,997,080 |
RGD:6480464 |
CTD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
multiple interactions |
ISO |
1 |
267,468,371 |
267,481,273 |
RGD:6480464 |
CTD |
| G |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
|
increases expression |
ISO |
2 |
244,949,303 |
245,035,266 |
RGD:6480464 |
CTD |
| G |
Prr14 |
proline rich 14 |
|
increases expression |
ISO |
1 |
186,729,277 |
186,764,463 |
RGD:6480464 |
CTD |
| G |
Prrg4 |
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) |
|
increases expression |
ISO |
3 |
90,174,070 |
90,198,654 |
RGD:6480464 |
CTD |
| G |
Psrc1 |
proline/serine-rich coiled-coil 1 |
|
decreases expression |
ISO |
2 |
203,952,299 |
203,956,742 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pthlh |
parathyroid hormone-like hormone |
|
decreases expression |
ISO |
4 |
184,887,702 |
184,898,841 |
RGD:6480464 |
CTD |
| G |
Pthlh |
parathyroid hormone-like hormone |
|
affects response to substance |
ISO |
4 |
184,887,702 |
184,898,841 |
RGD:6480464 |
CTD |
| G |
Pthlh |
parathyroid hormone-like hormone |
|
decreases expression |
ISO |
4 |
184,887,702 |
184,898,841 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
protein tyrosine kinase 2 |
|
decreases phosphorylation |
ISO |
7 |
110,933,298 |
111,084,554 |
RGD:6480464 |
CTD |
| G |
Ptk2 |
protein tyrosine kinase 2 |
|
increases expression |
ISO |
7 |
110,933,298 |
111,084,554 |
RGD:6480464 |
CTD |
| G |
Rab23 |
RAB23, member RAS oncogene family |
|
increases expression |
ISO |
9 |
32,465,752 |
32,486,615 |
RGD:6480464 |
CTD |
| G |
Rab27b |
RAB27B, member RAS oncogene family |
|
multiple interactions |
ISO |
18 |
66,682,627 |
66,747,813 |
RGD:6480464 |
CTD |
| G |
Rab32 |
RAB32, member RAS oncogene family |
|
multiple interactions |
ISO |
1 |
5,203,908 |
5,218,416 |
RGD:6480464 |
CTD |
| G |
Rab5b |
RAB5B, member RAS oncogene family |
|
multiple interactions |
ISO |
7 |
1,979,776 |
1,998,540 |
RGD:6480464 |
CTD |
| G |
Rab6a |
RAB6A, member RAS oncogene family |
|
increases expression |
ISO |
1 |
158,041,088 |
158,080,222 |
RGD:6480464 |
CTD |
| G |
Rabgap1l |
RAB GTPase activating protein 1-like |
|
multiple interactions |
ISO |
13 |
75,685,603 |
76,275,726 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
multiple interactions |
ISO |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Rad17 |
RAD17 homolog (S. pombe) |
|
multiple interactions |
ISO |
2 |
31,424,504 |
31,454,313 |
RGD:6480464 |
CTD |
| G |
Rad51d |
RAD51 homolog D (S. cerevisiae) |
|
increases expression |
ISO |
10 |
71,092,798 |
71,107,418 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
decreases expression |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
decreases geranoylation |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
multiple interactions |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
decreases prenylation |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
multiple interactions |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
decreases prenylation |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
decreases prenylation |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
decreases prenylation |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
decreases prenylation |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
decreases prenylation |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
decreases prenylation |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
decreases prenylation |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAP1A, member of RAS oncogene family |
|
decreases prenylation |
ISO |
2 |
200,980,324 |
201,001,561 |
RGD:6480464 |
CTD |
| G |
Rassf5 |
Ras association (RalGDS/AF-6) domain family member 5 |
|
increases expression |
ISO |
13 |
44,121,863 |
44,188,493 |
RGD:6480464 |
CTD |
| G |
Rbbp9 |
retinoblastoma binding protein 9 |
|
increases expression |
ISO |
3 |
133,091,157 |
133,097,910 |
RGD:6480464 |
CTD |
| G |
Rbm14 |
RNA binding motif protein 14 |
|
increases expression |
ISO |
1 |
207,410,484 |
207,421,760 |
RGD:6480464 |
CTD |
| G |
Rbm8a |
RNA binding motif protein 8A |
|
increases expression |
ISO |
2 |
191,429,805 |
191,432,261 |
RGD:6480464 |
CTD |
| G |
RGD1311723 |
similar to KIAA1731 protein |
|
increases expression |
ISO |
8 |
12,119,277 |
12,148,950 |
RGD:6480464 |
CTD |
| G |
RGD1560394 |
RGD1560394 |
|
decreases expression |
ISO |
14 |
82,462,073 |
82,463,678 |
RGD:6480464 |
CTD |
| G |
RGD1565712 |
similar to Hypothetical protein MGC59495 |
|
increases expression |
ISO |
1 |
85,585,510 |
85,597,999 |
RGD:6480464 |
CTD |
| G |
RGD735065 |
similar to GI:13385412-like protein splice form I |
|
increases expression |
ISO |
20 |
7,570,992 |
7,610,178 |
RGD:6480464 |
CTD |
| G |
Rgs11 |
regulator of G-protein signaling 11 |
|
multiple interactions |
ISO |
10 |
15,469,922 |
15,478,157 |
RGD:6480464 |
CTD |
| G |
Rgs14 |
regulator of G-protein signaling 14 |
|
increases expression |
ISO |
17 |
15,293,100 |
15,307,162 |
RGD:6480464 |
CTD |
| G |
Rhbdd2 |
rhomboid domain containing 2 |
|
increases expression |
ISO |
12 |
22,198,539 |
22,208,465 |
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
decreases geranoylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog family member A |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
increases expression |
ISO |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
multiple interactions |
ISO |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Rims2 |
regulating synaptic membrane exocytosis 2 |
|
multiple interactions |
ISO |
7 |
74,757,003 |
75,271,771 |
RGD:6480464 |
CTD |
| G |
Rin2 |
Ras and Rab interactor 2 |
|
multiple interactions |
ISO |
3 |
134,307,538 |
134,503,915 |
RGD:6480464 |
CTD |
| G |
Rnf114 |
ring finger protein 114 |
|
increases expression |
ISO |
3 |
158,650,310 |
158,662,425 |
RGD:6480464 |
CTD |
| G |
rnf141 |
ring finger protein 141 |
|
decreases expression |
ISO |
1 |
168,572,375 |
168,595,679 |
RGD:6480464 |
CTD |
| G |
Rnf167 |
ring finger protein 167 |
|
increases expression |
ISO |
10 |
57,527,033 |
57,531,325 |
RGD:6480464 |
CTD |
| G |
Rpl7 |
ribosomal protein L7 |
|
increases expression |
ISO |
5 |
2,315,766 |
2,318,774 |
RGD:6480464 |
CTD |
| G |
Rps9 |
ribosomal protein S9 |
|
decreases expression |
ISO |
1 |
63,824,657 |
63,828,046 |
RGD:6480464 |
CTD |
| G |
Rptor |
regulatory associated protein of MTOR, complex 1 |
|
decreases expression |
ISO |
10 |
109,000,666 |
109,302,700 |
RGD:6480464 |
CTD |
| G |
Rsrc1 |
arginine/serine-rich coiled-coil 1 |
|
decreases expression |
ISO |
2 |
156,889,768 |
157,213,294 |
RGD:6480464 |
CTD |
| G |
Scoc |
short coiled-coil protein |
|
increases expression |
ISO |
19 |
26,351,894 |
26,396,488 |
RGD:6480464 |
CTD |
| G |
Secisbp2l |
SECIS binding protein 2-like |
|
increases expression |
ISO |
3 |
113,048,593 |
113,092,428 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
increases expression |
ISO |
1 |
156,666,914 |
156,674,210 |
RGD:6480464 |
CTD |
| G |
Sfxn3 |
sideroflexin 3 |
|
decreases expression |
ISO |
1 |
250,113,685 |
250,122,002 |
RGD:6480464 |
CTD |
| G |
Shroom1 |
shroom family member 1 |
|
increases expression |
ISO |
10 |
38,925,114 |
38,935,035 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
increases expression |
ISO |
2 |
199,860,341 |
199,879,856 |
RGD:6480464 |
CTD |
| G |
Slc23a2 |
solute carrier family 23 (nucleobase transporters), member 2 |
|
increases expression |
ISO |
3 |
119,796,376 |
119,886,011 |
RGD:6480464 |
CTD |
| G |
Slc25a40 |
solute carrier family 25, member 40 |
|
increases expression |
ISO |
4 |
21,497,685 |
21,524,080 |
RGD:6480464 |
CTD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
increases expression |
ISO |
16 |
18,769,909 |
18,786,988 |
RGD:6480464 |
CTD |
| G |
Slco3a1 |
solute carrier organic anion transporter family, member 3a1 |
|
decreases expression |
ISO |
1 |
129,580,126 |
130,077,110 |
RGD:6480464 |
CTD |
| G |
Slmap |
sarcolemma associated protein |
|
increases expression |
ISO |
16 |
1,707,264 |
1,822,281 |
RGD:6480464 |
CTD |
| G |
Sos2 |
son of sevenless homolog 2 (Drosophila) |
|
multiple interactions |
ISO |
6 |
91,609,463 |
91,722,481 |
RGD:6480464 |
CTD |
| G |
Sox13 |
SRY (sex determining region Y)-box 13 |
|
increases expression |
ISO |
13 |
46,298,820 |
46,345,155 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
increases expression |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Spata7 |
spermatogenesis associated 7 |
|
increases expression |
ISO |
6 |
122,786,739 |
122,832,181 |
RGD:6480464 |
CTD |
| G |
Spin2a |
spindlin family, member 2A |
|
multiple interactions |
ISO |
X |
37,609,279 |
37,610,330 |
RGD:6480464 |
CTD |
| G |
Spryd3 |
SPRY domain containing 3 |
|
decreases expression |
ISO |
7 |
140,857,095 |
140,874,240 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
increases expression |
ISO |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
increases expression |
EXP |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Srsf11 |
serine/arginine-rich splicing factor 11 |
|
decreases expression |
ISO |
2 |
256,154,645 |
256,175,169 |
RGD:6480464 |
CTD |
| G |
Ss18 |
synovial sarcoma translocation, Chromosome 18 |
|
increases expression |
ISO |
18 |
5,870,874 |
5,934,171 |
RGD:6480464 |
CTD |
| G |
Ssx2ip |
synovial sarcoma, X breakpoint 2 interacting protein |
|
increases expression |
ISO |
2 |
244,604,360 |
244,637,562 |
RGD:6480464 |
CTD |
| G |
St6gal1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
increases expression |
ISO |
11 |
79,723,269 |
79,765,645 |
RGD:6480464 |
CTD |
| G |
Stk40 |
serine/threonine kinase 40 |
|
decreases expression |
ISO |
5 |
145,457,719 |
145,494,354 |
RGD:6480464 |
CTD |
| G |
Stx16 |
syntaxin 16 |
|
increases expression |
ISO |
3 |
164,995,189 |
165,022,884 |
RGD:6480464 |
CTD |
| G |
Stx17 |
syntaxin 17 |
|
increases expression |
ISO |
5 |
64,798,013 |
64,854,400 |
RGD:6480464 |
CTD |
| G |
Synj1 |
synaptojanin 1 |
|
increases expression |
ISO |
11 |
30,921,834 |
30,998,609 |
RGD:6480464 |
CTD |
| G |
Tab2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
|
increases expression |
ISO |
1 |
2,568,536 |
2,617,742 |
RGD:6480464 |
CTD |
| G |
Taf9b |
TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
increases expression |
ISO |
X |
94,342,071 |
94,351,927 |
RGD:6480464 |
CTD |
| G |
Tbl1xr1 |
transducin (beta)-like 1 X-linked receptor 1 |
|
increases expression |
ISO |
2 |
107,561,415 |
107,688,872 |
RGD:6480464 |
CTD |
| G |
Tcaim |
T cell activation inhibitor, mitochondrial |
|
increases expression |
ISO |
8 |
127,504,542 |
127,534,632 |
RGD:6480464 |
CTD |
| G |
Tfip11 |
tuftelin interacting protein 11 |
|
decreases expression |
ISO |
19 |
14,307,576 |
14,319,808 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
ISO |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tmco3 |
transmembrane and coiled-coil domains 3 |
|
increases expression |
ISO |
16 |
81,072,647 |
81,111,007 |
RGD:6480464 |
CTD |
| G |
Tmem30a |
transmembrane protein 30A |
|
increases expression |
ISO |
8 |
84,827,711 |
84,849,715 |
RGD:6480464 |
CTD |
| G |
Tmem87b |
transmembrane protein 87B |
|
increases expression |
ISO |
3 |
116,433,488 |
116,466,218 |
RGD:6480464 |
CTD |
| G |
Tmtc2 |
transmembrane and tetratricopeptide repeat containing 2 |
|
increases expression |
ISO |
7 |
43,667,983 |
44,133,854 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
affects expression |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
multiple interactions |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
increases expression |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
increases expression |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
increases secretion |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
increases expression |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
multiple interactions |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
increases expression |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
increases expression |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
multiple interactions |
ISO |
10 |
12,940,334 |
12,942,343 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
multiple interactions |
ISO |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
increases expression |
ISO |
4 |
162,172,563 |
162,185,252 |
RGD:6480464 |
CTD |
| G |
Tnfrsf21 |
tumor necrosis factor receptor superfamily, member 21 |
|
increases expression |
ISO |
9 |
13,587,961 |
13,666,380 |
RGD:6480464 |
CTD |
| G |
Tnfrsf25 |
tumor necrosis factor receptor superfamily, member 25 |
|
decreases expression |
ISO |
5 |
169,344,695 |
169,348,961 |
RGD:6480464 |
CTD |
| G |
Tnfrsf9 |
tumor necrosis factor receptor superfamily, member 9 |
|
decreases expression |
ISO |
5 |
168,071,159 |
168,099,501 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
affects expression |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
decreases expression |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
| G |
Tnfsf8 |
tumor necrosis factor (ligand) superfamily, member 8 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnpo3 |
transportin 3 |
|
decreases expression |
ISO |
4 |
56,422,446 |
56,499,733 |
RGD:6480464 |
CTD |
| G |
Tob1 |
transducer of ErbB-2.1 |
|
increases expression |
ISO |
10 |
82,852,405 |
82,854,443 |
RGD:6480464 |
CTD |
| G |
Tollip |
toll interacting protein |
|
increases expression |
ISO |
1 |
202,008,799 |
202,029,669 |
RGD:6480464 |
CTD |
| G |
Tox4 |
TOX high mobility group box family member 4 |
|
increases expression |
ISO |
15 |
27,729,485 |
27,743,620 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
multiple interactions |
ISO |
5 |
25,008,253 |
25,014,263 |
RGD:6480464 |
CTD |
| G |
Tradd |
TNFRSF1A-associated via death domain |
|
increases expression |
ISO |
19 |
35,073,150 |
35,075,251 |
RGD:6480464 |
CTD |
| G |
Traf2 |
Tnf receptor-associated factor 2 |
|
increases expression |
ISO |
3 |
3,692,740 |
3,717,332 |
RGD:6480464 |
CTD |
| G |
Traf3 |
Tnf receptor-associated factor 3 |
|
increases expression |
ISO |
6 |
135,925,375 |
136,027,270 |
RGD:6480464 |
CTD |
| G |
Traip |
TRAF-interacting protein |
|
increases expression |
ISO |
8 |
113,220,855 |
113,240,631 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
ISO |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Triqk |
triple QxxK/R motif containing |
|
increases expression |
ISO |
5 |
27,218,056 |
27,291,532 |
RGD:6480464 |
CTD |
| G |
Tsc22d3 |
TSC22 domain family, member 3 |
|
increases expression |
ISO |
X |
128,336,408 |
128,340,027 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
increases expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Ulk2 |
Unc-51 like kinase 2 (C. elegans) |
|
increases expression |
ISO |
10 |
47,931,165 |
48,009,986 |
RGD:6480464 |
CTD |
| G |
Unc13d |
unc-13 homolog D (C. elegans) |
|
increases expression |
ISO |
10 |
106,170,475 |
106,185,215 |
RGD:6480464 |
CTD |
| G |
Usp24 |
ubiquitin specific peptidase 24 |
|
decreases expression |
ISO |
5 |
127,371,225 |
127,500,521 |
RGD:6480464 |
CTD |
| G |
Usp31 |
ubiquitin specific peptidase 31 |
|
increases expression |
ISO |
1 |
180,465,513 |
180,502,558 |
RGD:6480464 |
CTD |
| G |
Vamp3 |
vesicle-associated membrane protein 3 |
|
increases expression |
ISO |
5 |
168,190,569 |
168,201,165 |
RGD:6480464 |
CTD |
| G |
Vangl1 |
VANGL planar cell polarity protein 1 |
|
decreases expression |
ISO |
2 |
197,248,680 |
197,296,021 |
RGD:6480464 |
CTD |
| G |
Vars |
valyl-tRNA synthetase |
|
increases expression |
ISO |
20 |
3,874,447 |
3,888,969 |
RGD:6480464 |
CTD |
| G |
Vash1 |
vasohibin 1 |
|
increases expression |
ISO |
6 |
110,806,294 |
110,818,161 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Wdr1 |
WD repeat domain 1 |
|
increases expression |
ISO |
14 |
77,489,828 |
77,524,430 |
RGD:6480464 |
CTD |
| G |
Wdtc1 |
WD and tetratricopeptide repeats 1 |
|
increases expression |
ISO |
5 |
151,784,746 |
151,834,368 |
RGD:6480464 |
CTD |
| G |
Whamm |
WAS protein homolog associated with actin, golgi membranes and microtubules |
|
increases expression |
ISO |
1 |
137,785,814 |
137,814,184 |
RGD:6480464 |
CTD |
| G |
Wnk1 |
WNK lysine deficient protein kinase 1 |
|
decreases expression |
ISO |
4 |
156,297,841 |
156,421,820 |
RGD:6480464 |
CTD |
| G |
Wnt11 |
wingless-type MMTV integration site family, member 11 |
|
multiple interactions |
ISO |
1 |
156,125,969 |
156,142,065 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
decreases expression |
ISO |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Ythdf3 |
YTH domain family, member 3 |
|
increases expression |
ISO |
2 |
100,852,768 |
100,885,774 |
RGD:6480464 |
CTD |
| G |
Zbtb4 |
zinc finger and BTB domain containing 4 |
|
decreases expression |
ISO |
10 |
56,596,070 |
56,602,532 |
RGD:6480464 |
CTD |
| G |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
|
increases expression |
ISO |
4 |
65,854,471 |
65,894,691 |
RGD:6480464 |
CTD |
| G |
Zfp36l2 |
zinc finger protein 36, C3H type-like 2 |
|
increases expression |
ISO |
6 |
7,530,948 |
7,534,988 |
RGD:6480464 |
CTD |
| G |
Zfp46 |
zinc finger protein 46 |
|
increases expression |
ISO |
5 |
155,035,876 |
155,040,376 |
RGD:6480464 |
CTD |
| G |
Zfp467 |
zinc finger protein 467 |
|
increases expression |
ISO |
4 |
76,522,000 |
76,528,470 |
RGD:6480464 |
CTD |
| G |
Zfp498 |
zinc finger protein 498 |
|
increases expression |
ISO |
12 |
9,640,243 |
9,650,703 |
RGD:6480464 |
CTD |
| G |
Zfp644 |
zinc finger protein 644 |
|
increases expression |
ISO |
14 |
3,645,610 |
3,720,694 |
RGD:6480464 |
CTD |
Term paths to the root
|